Vantaggi
Smart, innovative and creative people work(ed) here but any attempts at change are immediately hampered by middle management that simply don't understand the business or are threatened by new approaches.
Svantaggi
Huge potential to exploit revenue streams not directly tied to declining Pharma dollars However, the recruitment of an "industry insider" CEO does not bode well for any approach other than that of doubling down on previous bad bets.. Employee morale is abysmal. Anyone who has an opportunity to leave (ie: the most talented employess) has left or has one foot out the door. By Q2 2013 this company will be full of mediocre resources at best. Actually heard an executive quote "content is king" in a recent meeting. What year are they operating in? Toxic culture that rewards managing up rather than managing the business.